603077 和邦生物
已收盘 11-20 15:00:00
资讯
新帖
简况
股市必读:和邦生物(603077)11月20日董秘有最新回复
证券之星 · 02:03
股市必读:和邦生物(603077)11月20日董秘有最新回复
和邦生物:公司目前生产经营正常,控股股东资信状况良好
证券之星 · 11-20 16:57
和邦生物:公司目前生产经营正常,控股股东资信状况良好
和邦生物(603077)11月17日主力资金净买入2275.09万元
证券之星 · 11-18
和邦生物(603077)11月17日主力资金净买入2275.09万元
股市必读:和邦生物新发布《和邦生物2026年第三次临时股东会决议公告》
证券之星 · 11-16
股市必读:和邦生物新发布《和邦生物2026年第三次临时股东会决议公告》
和邦生物(603077)披露2026年第三次临时股东会决议公告,11月13日股价下跌1.49%
证券之星 · 11-13
和邦生物(603077)披露2026年第三次临时股东会决议公告,11月13日股价下跌1.49%
和邦生物:员工持股计划锁定期届满后的股份处置行为
证券之星 · 11-13
和邦生物:员工持股计划锁定期届满后的股份处置行为
和邦生物:公司各项海外投资均严格履行了审慎决策程序
证券之星 · 11-13
和邦生物:公司各项海外投资均严格履行了审慎决策程序
股市必读:和邦生物(603077)11月6日董秘有最新回复
证券之星 · 11-09
股市必读:和邦生物(603077)11月6日董秘有最新回复
和邦生物:现有双甘膦产能20万吨/年、草甘膦产能6万吨/年
证券之星 · 11-06
和邦生物:现有双甘膦产能20万吨/年、草甘膦产能6万吨/年
和邦生物:贺正刚先生本次减持严格遵守相关法律法规及监管要求
证券之星 · 11-06
和邦生物:贺正刚先生本次减持严格遵守相关法律法规及监管要求
和邦生物:公司2026年11月5日收盘价为2.09元,高于2025年末经审计每股净资产1.983元
证券之星 · 11-06
和邦生物:公司2026年11月5日收盘价为2.09元,高于2025年末经审计每股净资产1.983元
和邦生物:公司始终专注于主营业务发展
证券之星 · 11-06
和邦生物:公司始终专注于主营业务发展
股市必读:和邦生物(603077)10月30日董秘有最新回复
证券之星 · 11-02
股市必读:和邦生物(603077)10月30日董秘有最新回复
和邦生物:公司始终将做好主业经营作为维护市值的根本
证券之星 · 10-30
和邦生物:公司始终将做好主业经营作为维护市值的根本
和邦生物:双甘膦、草甘膦及副产品的经营数据受市场供需与行业周期等多重因素影响
证券之星 · 10-30
和邦生物:双甘膦、草甘膦及副产品的经营数据受市场供需与行业周期等多重因素影响
股市必读:和邦生物三季报 - 第三季度单季净利润同比增长78.35%
证券之星 · 10-28
股市必读:和邦生物三季报 - 第三季度单季净利润同比增长78.35%
和邦生物(603077)披露2026年第三季度报告议案,10月26日股价下跌0.48%
证券之星 · 10-26
和邦生物(603077)披露2026年第三季度报告议案,10月26日股价下跌0.48%
和邦生物(603077)9月30日股东户数24.34万户,较上期增加3.04%
证券之星 · 10-26
和邦生物(603077)9月30日股东户数24.34万户,较上期增加3.04%
和邦生物最新公告:前三季度净利润同比增长387.48%
证券之星 · 10-26
和邦生物最新公告:前三季度净利润同比增长387.48%
股市必读:和邦生物(603077)10月23日董秘有最新回复
证券之星 · 10-26
股市必读:和邦生物(603077)10月23日董秘有最新回复
加载更多
公司概况
公司名称:
四川和邦生物科技股份有限公司
所属行业:
化学原料和化学制品制造业
上市日期:
2012-07-31
主营业务:
四川和邦生物科技股份有限公司的主营业务是化工、农药、饲料添加剂、玻璃及制品、光伏材料及制品制造以及盐矿、磷矿的开发。公司的主要产品是磷矿、盐矿、联碱产品、双甘膦、草甘膦、二乙腈、蛋氨酸、智能玻璃、光伏玻璃及组件、硅片、农药产品,光伏工程建设、天然气管道运输及转供、成品油销售。
发行价格:
17.50
{"stockData":{"symbol":"603077","market":"SH","secType":"STK","nameCN":"和邦生物","latestPrice":1.87,"timestamp":1795158000000,"preClose":1.92,"halted":0,"volume":100338769,"delay":0,"changeRate":-0.026,"floatShares":8832000000,"shares":8832000000,"eps":-0.0199,"marketStatus":"已收盘","change":-0.05,"latestTime":"11-20 15:00:00","open":1.9,"high":1.91,"low":1.86,"amount":189000000,"amplitude":0.026,"askPrice":1.88,"askSize":5468,"bidPrice":1.87,"bidSize":19450,"shortable":0,"etf":0,"ttmEps":-0.0199,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1795397400000},"marketStatusCode":5,"adr":0,"adjPreClose":1.92,"symbolType":"stock","openAndCloseTimeList":[[1795138200000,1795145400000],[1795150800000,1795158000000]],"highLimit":2.11,"lowLimit":1.73,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":8831762728,"isCdr":false,"pbRate":0.86,"roa":"--","roe":"2.44%","epsLYR":-0.0672,"committee":0.007591,"marketValue":16515000000,"turnoverRate":0.0114,"status":1,"floatMarketCap":16515000000},"requestUrl":"/m/hq/s/603077","defaultTab":"news","newsList":[{"id":"2685145840","title":"股市必读:和邦生物(603077)11月20日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2685145840","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2685145840?lang=zh_cn&edition=full","pubTime":"2026-11-23 02:03","pubTimestamp":1795370598,"startTime":"0","endTime":"0","summary":"截至2026年11月20日收盘,和邦生物报收于1.87元,下跌2.6%,换手率1.14%,成交量100.34万手,成交额1.89亿元。董秘最新回复投资者: 距离贺正刚股份减持到期时间还剩余24个交易日,贺正刚股份减持了多少了?网络空间并非法外之地,公司保留对不实言论追究法律责任的权利。当日关注点交易信息汇总:11月20日主力资金净流出1537.65万元,占总成交额8.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026112300000718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603077","BK0132","BK0077","BK0196","BK0027","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684213212","title":"和邦生物:公司目前生产经营正常,控股股东资信状况良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2684213212","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684213212?lang=zh_cn&edition=full","pubTime":"2026-11-20 16:57","pubTimestamp":1795165057,"startTime":"0","endTime":"0","summary":"证券之星消息,和邦生物(603077)11月20日在投资者关系平台上答复投资者关心的问题。投资者提问:跌破净值了,可以注销回购股票了,不然一直跌,大股东要爆仓了和邦生物回复:尊敬的投资者您好,公司目前生产经营正常,控股股东资信状况良好。请广大投资者不信谣、不传谣,理性投资。关于公司回购专用证券账户中已回购股份的相关安排,届时公司将根据资金状况及市场状况判断后,提请相应审议程序并披露,请以公司在上海证券交易所网站及指定信息披露媒体披露的公告为准。感谢您的关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026112000029444.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0196","BK0132","BK0229","603077","BK0027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684250937","title":"和邦生物(603077)11月17日主力资金净买入2275.09万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2684250937","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684250937?lang=zh_cn&edition=full","pubTime":"2026-11-18 08:21","pubTimestamp":1794961277,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月17日收盘,和邦生物报收于1.98元,上涨1.54%,换手率1.13%,成交量99.98万手,成交额1.97亿元。11月17日的资金流向数据方面,主力资金净流入2275.09万元,占总成交额11.53%,游资资金净流出1036.73万元,占总成交额5.25%,散户资金净流出1238.37万元,占总成交额6.28%。和邦生物主营业务:化工、农药、饲料添加剂、玻璃及制品、光伏材料及制品制造以及盐矿、磷矿的开发。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111800009648.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0196","BK0027","BK0229","BK0077","603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683665035","title":"股市必读:和邦生物新发布《和邦生物2026年第三次临时股东会决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2683665035","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683665035?lang=zh_cn&edition=full","pubTime":"2026-11-16 04:13","pubTimestamp":1794773593,"startTime":"0","endTime":"0","summary":"和邦生物2026年第三次临时股东会法律意见书北京国枫律师事务所出具法律意见书,认为本次股东大会的召集、召开程序,召集人和出席会议人员资格,以及表决程序和表决结果均符合相关法律法规及公司章程的规定,合法有效;会议审议通过了续聘会计师事务所的议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111600001367.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0027","BK0229","BK0132","BK0077","603077","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683501833","title":"和邦生物(603077)披露2026年第三次临时股东会决议公告,11月13日股价下跌1.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2683501833","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683501833?lang=zh_cn&edition=full","pubTime":"2026-11-13 22:49","pubTimestamp":1794581370,"startTime":"0","endTime":"0","summary":"截至2026年11月13日收盘,和邦生物报收于1.99元,较前一交易日下跌1.49%,最新总市值为175.75亿元。该股当日开盘2.02元,最高2.03元,最低1.99元,成交额达1.52亿元,换手率为0.86%。近日,和邦生物发布《2026年第三次临时股东会决议公告》。公告显示,公司于2026年11月13日在四川省成都市召开2026年第三次临时股东会,会议由董事长曾小平主持,采用现场与网络投票相结合方式举行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111300044279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0077","BK0027","BK0229","BK0196","603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683666578","title":"和邦生物:员工持股计划锁定期届满后的股份处置行为","url":"https://stock-news.laohu8.com/highlight/detail?id=2683666578","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683666578?lang=zh_cn&edition=full","pubTime":"2026-11-13 16:18","pubTimestamp":1794557907,"startTime":"0","endTime":"0","summary":"员工持股计划锁定期届满后的股份处置行为,属于该计划在符合监管规则前提下的正常退出安排,不应被曲解为恶意扰乱市场。关于第四期员工持股计划锁定期届满后的具体安排,请以公司后续在上海证券交易所网站及指定信息披露媒体披露的公告为准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111300027882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","BK0196","603077","BK0077","BK0027","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683578668","title":"和邦生物:公司各项海外投资均严格履行了审慎决策程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2683578668","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683578668?lang=zh_cn&edition=full","pubTime":"2026-11-13 16:18","pubTimestamp":1794557895,"startTime":"0","endTime":"0","summary":"证券之星消息,和邦生物(603077)11月13日在投资者关系平台上答复投资者关心的问题。投资者提问:尼日利亚的项目是不是都很难落地?投资会像以色列STK一样打水漂吗?和邦生物海外投资怎么像散财童子到处撒钱?和邦生物回复:尊敬的投资者您好,公司各项海外投资均严格履行了审慎决策程序。相关项目正按既定规划稳步推进,不存在您所述的相关情形。敬请基于客观事实理性判断,切勿进行无事实依据的揣测,以免误导其他投资者。有关项目最新进展,请以公司在上海证券交易所网站及指定信息披露媒体披露的公告为准。感谢您的关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111300027862.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0027","BK0077","BK0229","603077","BK0132","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682826957","title":"股市必读:和邦生物(603077)11月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2682826957","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682826957?lang=zh_cn&edition=full","pubTime":"2026-11-09 03:34","pubTimestamp":1794166451,"startTime":"0","endTime":"0","summary":"截至2026年11月6日收盘,和邦生物报收于2.06元,下跌1.44%,换手率0.92%,成交量81.24万手,成交额1.68亿元。董秘最新回复投资者: 五线顺下,还得有大跌?目前,公司整体生产经营保持稳健态势,产销衔接良好。近期监管部门持续推动股票回购增持再贷款政策落实。公司将继续严格按照既定方案及监管要求妥善处理。公司此前披露实际控制人贺正刚拟减持股份。涉及公司的重大事项,公司将依照相关规定履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110900001001.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0229","BK0077","603077","BK0027","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681859948","title":"和邦生物:现有双甘膦产能20万吨/年、草甘膦产能6万吨/年","url":"https://stock-news.laohu8.com/highlight/detail?id=2681859948","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681859948?lang=zh_cn&edition=full","pubTime":"2026-11-06 17:04","pubTimestamp":1793955894,"startTime":"0","endTime":"0","summary":"证券之星消息,和邦生物(603077)11月06日在投资者关系平台上答复投资者关心的问题。投资者提问:公司草甘膦、双甘膦现有产能多少?在建产能能达到多少?在建产能分别什么时候能真正投料试产?和邦生物回复:尊敬的投资者您好,公司现有双甘膦产能20万吨/年、草甘膦产能6万吨/年。在建项目为广安年产50万吨双甘膦项目和印尼年产35万吨草甘膦项目,两项目当前整体工程进度符合预期。根据公司目前的工程计划,广安年产50万吨双甘膦项目拟于2027年10月建设完毕后进入投料试生产。感谢您的关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600028558.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","BK0132","603077","BK0027","BK0077","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681859672","title":"和邦生物:贺正刚先生本次减持严格遵守相关法律法规及监管要求","url":"https://stock-news.laohu8.com/highlight/detail?id=2681859672","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681859672?lang=zh_cn&edition=full","pubTime":"2026-11-06 17:04","pubTimestamp":1793955894,"startTime":"0","endTime":"0","summary":"证券之星消息,和邦生物11月06日在投资者关系平台上答复投资者关心的问题。公司此前披露实际控制人贺正刚拟减持股份。关于贺正刚先生的减持进展及结果,公司将依照相关规定履行信息披露义务,请您关注公司在上海证券交易所网站及指定信息披露媒体发布的公告。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600028557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","BK0196","603077","BK0077","BK0027","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681859993","title":"和邦生物:公司2026年11月5日收盘价为2.09元,高于2025年末经审计每股净资产1.983元","url":"https://stock-news.laohu8.com/highlight/detail?id=2681859993","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681859993?lang=zh_cn&edition=full","pubTime":"2026-11-06 17:04","pubTimestamp":1793955888,"startTime":"0","endTime":"0","summary":"请明确:1.公司连续破净起算日及认定口径;2.若达到《上市公司监管指引第10号》规定的长期破净标准,是否将依法制定并披露估值提升计划;3.公司2026年行动方案明确提及《市值管理制度》,为何不公开全文?和邦生物回复:尊敬的投资者您好,公司2026年11月5日收盘价为2.09元,高于2025年末经审计每股净资产1.983元,未触及破净情形,故不存在连续破净起算日,亦不涉及《上市公司监管指引第10号》关于长期破净公司的要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600028553.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","BK0132","603077","BK0027","BK0077","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681859914","title":"和邦生物:公司始终专注于主营业务发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2681859914","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681859914?lang=zh_cn&edition=full","pubTime":"2026-11-06 17:04","pubTimestamp":1793955887,"startTime":"0","endTime":"0","summary":"证券之星消息,和邦生物(603077)11月06日在投资者关系平台上答复投资者关心的问题。投资者提问:等我清仓了三峡新材之后过来入手和邦生物,再挣一个小目标可好?和邦生物的故事也该讲到高潮了吧?和邦生物回复:尊敬的投资者您好,公司始终专注于主营业务发展,不存在您所提及的“讲故事”情形。公司具体经营情况及重大事项,请以公司在上海证券交易所网站及指定信息披露媒体发布的正式公告为准。二级市场股价受行业周期、市场供需、资金面及投资者情绪等多重因素影响,请您基于自身风险承受能力审慎决策、理性投资,注意风险。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600028550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0027","BK0229","BK0077","BK0196","603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680720092","title":"股市必读:和邦生物(603077)10月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2680720092","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680720092?lang=zh_cn&edition=full","pubTime":"2026-11-02 04:58","pubTimestamp":1793566689,"startTime":"0","endTime":"0","summary":"截至2026年10月30日收盘,和邦生物报收于2.0元,下跌0.5%,换手率0.98%,成交量86.24万手,成交额1.73亿元。如有达到披露标准的市值维护举措,公司将及时公告。当日关注点交易信息汇总:10月30日主力资金净流入1248.7万元,占总成交额7.21%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200001445.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0027","BK0132","BK0077","BK0229","603077","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679260998","title":"和邦生物:公司始终将做好主业经营作为维护市值的根本","url":"https://stock-news.laohu8.com/highlight/detail?id=2679260998","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679260998?lang=zh_cn&edition=full","pubTime":"2026-10-30 16:09","pubTimestamp":1793347751,"startTime":"0","endTime":"0","summary":"是否能拿出点维护公司市值的实际行动?二级市场股价受宏观经济、行业环境及市场情绪等多重因素综合影响,公司始终尊重并维护全体股东的合法权益。公司管理层始终将做好主业经营作为维护市值的根本,持续提升经营质量、推进重点项目落地、不断提升公司内在价值。如有达到披露标准的市值维护举措,公司将及时公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000037967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0196","BK0027","BK0229","BK0077","603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679999260","title":"和邦生物:双甘膦、草甘膦及副产品的经营数据受市场供需与行业周期等多重因素影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2679999260","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679999260?lang=zh_cn&edition=full","pubTime":"2026-10-30 16:09","pubTimestamp":1793347750,"startTime":"0","endTime":"0","summary":"证券之星消息,和邦生物(603077)10月30日在投资者关系平台上答复投资者关心的问题。投资者提问:双甘膦、草甘膦及副产品,为什么公告今年比去年低?和邦生物回复:尊敬的投资者您好,双甘膦、草甘膦及副产品的经营数据受市场供需与行业周期等多重因素影响,不同报告期数据存在合理差异属正常现象。具体请以公司定期报告及主要经营数据公告为准。感谢您的关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000037966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603077","BK0027","BK0132","BK0077","BK0196","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678410008","title":"股市必读:和邦生物三季报 - 第三季度单季净利润同比增长78.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678410008","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678410008?lang=zh_cn&edition=full","pubTime":"2026-10-28 03:52","pubTimestamp":1793130769,"startTime":"0","endTime":"0","summary":"当日关注点交易信息汇总:10月27日主力资金净流出2137.25万元,占总成交额13.31%; 业绩披露要点:2026年三季报显示归母净利润4.54亿元,同比上升387.48%; 公司公告汇总:董事会审议通过续聘四川华信(集团)会计师事务所为2026年度审计机构,审计费用合计140.80万元,并拟提交股东会审议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800003485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678943821","title":"和邦生物(603077)披露2026年第三季度报告议案,10月26日股价下跌0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678943821","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678943821?lang=zh_cn&edition=full","pubTime":"2026-10-26 22:37","pubTimestamp":1793025449,"startTime":"0","endTime":"0","summary":"截至2026年10月26日收盘,和邦生物报收于2.08元,较前一交易日下跌0.48%,最新总市值为183.7亿元。该股当日开盘2.07元,最高2.09元,最低2.05元,成交额达1.35亿元,换手率为0.74%。近日,四川和邦生物科技股份有限公司召开第七届董事会第五次会议,审议通过《关于<公司2026年第三季度报告>的议案》,同意披露公司2026年第三季度报告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600037893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0027","BK0132","BK0077","BK0229","603077","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678169970","title":"和邦生物(603077)9月30日股东户数24.34万户,较上期增加3.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678169970","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678169970?lang=zh_cn&edition=full","pubTime":"2026-10-26 17:53","pubTimestamp":1793008386,"startTime":"0","endTime":"0","summary":"证券之星消息,近日和邦生物披露,截至2026年9月30日公司股东户数为24.34万户,较6月30日增加7190.0户,增幅为3.04%。在农化制品行业个股中,和邦生物股东户数高于行业平均水平,截至9月30日,农化制品行业平均股东户数为4.82万户。从股价来看,2026年6月30日至2026年9月30日,和邦生物区间跌幅为5.6%,在此期间股东户数增加7190.0户,增幅为3.04%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600024043.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0027","BK0196","BK0229","603077","BK0132","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678869169","title":"和邦生物最新公告:前三季度净利润同比增长387.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678869169","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678869169?lang=zh_cn&edition=full","pubTime":"2026-10-26 17:34","pubTimestamp":1793007261,"startTime":"0","endTime":"0","summary":"和邦生物(603077.SH)公告称,第三季度营业收入为16.34亿元,同比下降18.52%;归属于上市公司股东的净利润为7372.54万元,同比增长78.35%。前三季度实现营业收入45.22亿元,同比下降23.70%;归属于上市公司股东的净利润为4.54亿元,同比增长387.48%。注:公司Q3净利润0.74亿,Q2净利润2.07亿,据此计算,Q3净利润环比下降64%。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600023553.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678139847","title":"股市必读:和邦生物(603077)10月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2678139847","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678139847?lang=zh_cn&edition=full","pubTime":"2026-10-26 03:55","pubTimestamp":1792958110,"startTime":"0","endTime":"0","summary":"截至2026年10月23日收盘,和邦生物报收于2.09元,上涨0.97%,换手率1.36%,成交量120.03万手,成交额2.45亿元。根据目前的工程计划,该项目预计于2027年10月建设完毕后进入投料试生产。截至目前,公司暂未发现影响项目推进的重大不确定因素。当日关注点交易信息汇总:10月23日主力资金净流出697.89万元,占总成交额2.85%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600000995.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0027","BK0077","BK0196","BK0229","603077"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1795390801227,"stockEarnings":[{"period":"1week","weight":-0.0603},{"period":"1month","weight":-0.1179},{"period":"3month","weight":-0.211},{"period":"6month","weight":-0.289},{"period":"1year","weight":-0.1905},{"period":"ytd","weight":-0.1726}],"compareEarnings":[{"period":"1week","weight":-0.0277},{"period":"1month","weight":-0.0483},{"period":"3month","weight":-0.0951},{"period":"6month","weight":-0.1408},{"period":"1year","weight":-0.1011},{"period":"ytd","weight":-0.1096}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"四川和邦生物科技股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"243426人(较上一季度增加3.04%)","perCapita":"36281股","listingDate":"2012-07-31","address":"四川省乐山市五通桥区牛华镇沔坝村","registeredCapital":"883176万元","survey":" 四川和邦生物科技股份有限公司的主营业务是化工、农药、饲料添加剂、玻璃及制品、光伏材料及制品制造以及盐矿、磷矿的开发。公司的主要产品是磷矿、盐矿、联碱产品、双甘膦、草甘膦、二乙腈、蛋氨酸、智能玻璃、光伏玻璃及组件、硅片、农药产品,光伏工程建设、天然气管道运输及转供、成品油销售。","listedPrice":17.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和邦生物(603077)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和邦生物(603077)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和邦生物,603077,和邦生物股票,和邦生物股票老虎,和邦生物股票老虎国际,和邦生物行情,和邦生物股票行情,和邦生物股价,和邦生物股市,和邦生物股票价格,和邦生物股票交易,和邦生物股票购买,和邦生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和邦生物(603077)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和邦生物(603077)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}